Skip to main content
. 2012 Nov 28;21(6):695–697. doi: 10.1038/ejhg.2012.241

Table 1. Follow-up of the MEN1 putative mutation' carriers.

Medical visit as outpatients Biannually Anamnesis and physical examination
Blood sampling Biannually TSH, fT4, PRL, ACTH, cortisol, gastrin, fasting insulin, fasting glucagon, fasting glucose, fasting C-peptide, fasting IGF-1, calcium, chloride, phosphate, PTH, liver enzymes
Urine sampling 24-h collect Biannually Calciuria Catecholamines (5-HIAA, HVA and VMA)
Imaging studies When indicated Parathyroids US
Imaging studies Every 2 years MRI of the pituitary sella MRI of the abdomen

Abbreviations: ACTH, adrenocorticotropic hormone; HVA, homovanillic acid; IGF-1, insulin-like growth factor; MEN1, multiple endocrine neoplasia type 1; MRI, magnetic resonance imaging; PRL, prolactin; PTH, parathyroid hormone; TSH, thyroid stimulating hormone; T4, thyroxine; US, ultrasound; VMA, vanillyl mandelic acid; 5-HIAA, 5-hydroxyindoleacetic acid.